Kymera Therapeutics, Inc. Logo

Kymera Therapeutics, Inc.

Fintech firm providing data analytics and market intelligence for investment professionals.

KYMR | NDAQ

Overview

Corporate Details

ISIN(s):
US5015751044
LEI:
Country:
United States of America
Address:
500 NORTH BEACON STREET, 4TH FLOOR, 2472 WATERTOWN
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Kymera Therapeutics, Inc. is a revolutionary financial technology firm redefining investment paradigms through targeted data analytics. Leveraging its powerful and highly productive data discovery engine, the company delivers a pipeline of first-in-class analytics and market intelligence solutions for financial institutions and investment professionals. Kymera's platform provides a market-agnostic modality for discovering alpha and managing risk, fundamentally changing how clients access and utilize data. The firm is committed to delivering transformative insights with precision, focus, and a sense of urgency to a global client base.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-04 13:15
Quarterly Report
10-Q - Kymera Therapeutics, Inc. (0001815442) (Filer)
English 2.2 MB
2025-11-04 13:10
Regulatory News Service
8-K - Kymera Therapeutics, Inc. (0001815442) (Filer)
English 225.9 KB

Automate Your Workflow. Get a real-time feed of all Kymera Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kymera Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kymera Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Larimar Therapeutics, Inc. Logo
Clinical-stage biotech developing protein therapies for rare diseases like Friedreich's ataxia.
United States of America LRMR
LEAP THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing targeted immuno-oncology antibody therapies for cancer.
United States of America LPTX
Lidds AB Logo
Develops oncology drugs using a technology for local, controlled, and sustained drug release.
Sweden LIDDS
LigaChem Biosciences Inc. Logo
Advancing a next-gen ADC platform to develop innovative medicines for unmet needs.
South Korea 141080
LIGAND PHARMACEUTICALS INC Logo
Acquires drug royalties and licenses proprietary technologies to biopharmaceutical partners.
United States of America LGND
LIKE,Inc. Logo
Provides comprehensive lifestyle support in childcare, human resources, and nursing care services.
Japan 2462
Linical Co., Ltd. Logo
Global CRO providing full-service drug development support for biopharma companies.
Japan 2183
Linkers Corporation Logo
A technology matchmaking platform for manufacturers to solve challenges and foster innovation.
Japan 5131
Lipidor AB Logo
Develops topical skin treatments by reformulating drugs with a lipid-based delivery platform.
Sweden LIPI
MAIA Biotechnology, Inc. Logo
Developing telomere-targeting immuno-oncology therapies for difficult-to-treat cancers.
United States of America MAIA

Talk to a Data Expert

Have a question? We'll get back to you promptly.